Literature DB >> 16270203

[Calcinosis cutis in Albright hereditary osteodystrophy: pseudohypoparathyroidism type Ia].

R Fölster-Holst1, F G Riepe, W Ahrens, M Möller, J Brasch, C-J Partsch, O Hiort, W G Sippell.   

Abstract

Albright hereditary osteodystrophy (AHO) is characterized by a symptom complex including short stature, brachymetacarpia, obesity, round facies, cutaneous osteomas, and mental retardation. AHO is caused by mutations in the GNAS-gene localized on chromosome 20 encoding for Gsalpha protein, a signal transducer of endocrine pathways. Therefore, AHO is often associated with endocrinopathy such as pseudohypoparathyroidism or hypothyroidism. A nine-month-old boy presented with typical features of this syndrome. The diagnosis was confirmed by biochemical and molecular analyses. An unusual feature was calcinosis cutis at such an early age, which led to extensive differential diagnostic procedures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16270203     DOI: 10.1007/s00105-005-1040-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  12 in total

1.  Tissue-specific imprinting of the G protein Gsalpha is associated with tissue-specific differences in histone methylation.

Authors:  Akio Sakamoto; Jie Liu; Andrew Greene; Min Chen; Lee S Weinstein
Journal:  Hum Mol Genet       Date:  2004-02-19       Impact factor: 6.150

2.  Early manifestation of calcinosis cutis in pseudohypoparathyroidism type Ia associated with a novel mutation in the GNAS gene.

Authors:  Felix G Riepe; Wiebke Ahrens; Nils Krone; Regina Fölster-Holst; Jochen Brasch; Wolfgang G Sippell; Olaf Hiort; Carl-Joachim Partsch
Journal:  Eur J Endocrinol       Date:  2005-04       Impact factor: 6.664

3.  Osteoma cutis as a presenting sign of pseudohypoparathyroidism.

Authors:  J S Prendiville; A W Lucky; S B Mallory; Z Mughal; F Mimouni; C B Langman
Journal:  Pediatr Dermatol       Date:  1992-03       Impact factor: 1.588

4.  Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism.

Authors:  Luisa De Sanctis; Damiano Romagnolo; Martina Olivero; Fabio Buzi; Mohamad Maghnie; Giuseppe Scirè; Antonio Crino; Giampiero Igli Baroncelli; Mariacarolina Salerno; Salvatore Di Maio; Marco Cappa; Salvatore Grosso; Franco Rigon; Roberto Lala; Carlo De Sanctis; Irma Dianzani
Journal:  Pediatr Res       Date:  2003-03-05       Impact factor: 3.756

5.  A factor produced by cultured rat Leydig tumor (Rice 500) cells associated with humoral hypercalcemia stimulates adenosine 3',5'-monophosphate production via the parathyroid hormone receptor in human skin fibroblasts.

Authors:  C Silve; A Santora; A Spiegel
Journal:  J Clin Endocrinol Metab       Date:  1985-06       Impact factor: 5.958

6.  [Primary cutaneous osteoma in hereditary Albright osteodystrophy].

Authors:  K Diercks; K Schulte; H C Schuppe; P Lehmann
Journal:  Hautarzt       Date:  1996-09       Impact factor: 0.751

Review 7.  Pseudohypoparathyroidism. New insights into an old disease.

Authors:  M Bastepe; H Jüppner
Journal:  Endocrinol Metab Clin North Am       Date:  2000-09       Impact factor: 4.741

8.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Authors:  L S Weinstein; A Shenker; P V Gejman; M J Merino; E Friedman; A M Spiegel
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

9.  Response to hormones of cells cultured from human giant cell tumors of bone.

Authors:  S R Goldring; J M Dayer; R G Russell; H J Mankin; S M Krane
Journal:  J Clin Endocrinol Metab       Date:  1978-03       Impact factor: 5.958

10.  A new heterozygous mutation (L338N) in the human Gsalpha (GNAS1) gene as a cause for congenital hypothyroidism in Albright's hereditary osteodystrophy.

Authors:  Joachim Pohlenz; Wiebke Ahrens; Olaf Hiort
Journal:  Eur J Endocrinol       Date:  2003-04       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.